Founded 2019; joined incubator December 2021
Stage Revenue
Investor Trendlines Incubators Israel
CEO Udi Peretz
SOLVEAT develops unique nutritional solutions that transform ordinary foods to functional. This by introducing innovative and highly technological herbal compositions that target high impact medical conditions.
Our first target is prediabetes, which affects hundreds of millions worldwide and eventually leads to diabetes – a devastating disease that significantly impair patients’ quality of life and responsible for 5 million deaths every year.
Udi is an expert in herbal extracts, industrial operations and management. Udi holds a MSc. in Microbiology from Hebrew University and has held various leadership positions in pharma, food and biotech companies in Israel and in China (Teva, Gadot, Amgal and Kamedis).
Prior to founding SOLVEAT, Udi was managing and operating a herbal biotechnological company in China that developed and manufactured high standard proprietary extracts.
Zakhar Nudelman brings over a decade of experience in biotechnology, business development, product development and commercialization.
Zakhar, a pharmacist by training and holds a Ph.D. in pharmaceutical sciences and a MBA (Biomed) from the Hebrew University of Jerusalem, Israel.
Tal Naveh is a Traditional Chinese Medicine (TCM) specialist and practitioner running a successful practice in Tel Aviv, Israel.
Tal received his education in Chinese medicine at the Tel Aviv University.
Tal brings expertise in Traditional Chinese Medicine and a deep understanding of needs of Western patients.
The global functional foods market is estimated at USD 250 billion and it is anticipated to grow at CAGR of 7.9% in the forthcoming years. Today, the phytochemicals & plant extracts segment of the global functional food ingredients market is valued at USD 5 billion and growing at CAGR of 6.8%.
SOLVEAT’s approach is in line with key food industry drivers:
• Shifting to healthier and natural solutions.
• Need for quality and transparency.
• Major demand for solid scientific, clinical and technological basis along with innovation in the field of food.
Our first target is prediabetes, which affects hundreds of millions worldwide and eventually leads to diabetes – a devastating disease that significantly impair patients’ quality of life and responsible for 5 million deaths every year.
